Tolerability of enalapril in congestive heart failure.

[1]  M. Packer,et al.  Comparison of captopril and enalapril in patients with severe chronic heart failure. , 1986, The New England journal of medicine.

[2]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[3]  B. W. East,et al.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. , 1985, British heart journal.

[4]  M. Packer,et al.  Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study. , 1985, American heart journal.

[5]  I. Tikkanen,et al.  Evidence that renin substrate (angiotensinogen) may be a precursor of erythropoietin. , 1985, Scandinavian journal of urology and nephrology. Supplementum.

[6]  B. W. East,et al.  Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.

[7]  D. Sharpe,et al.  Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. , 1984, Circulation.

[8]  M. Packer,et al.  Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. , 1984, Journal of the American College of Cardiology.

[9]  E. Espiner,et al.  Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. , 1983, British heart journal.

[10]  B. Massie,et al.  Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study , 1983, Circulation.

[11]  S. Chrysant,et al.  Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. , 1983, Archives of internal medicine.